Company Filing History:
1 out of 38 
1 out of 280 
1 out of 15 Years Active: 2025
Title: Antonio Maraver: Innovator in Cancer Treatment
Introduction
Antonio Maraver is a notable inventor based in Montpellier, France. He has made significant contributions to the field of cancer treatment, particularly focusing on lung cancer. His innovative approach combines the use of tyrosine-kinase inhibitors with Notch pathway inhibitors to enhance treatment efficacy.
Latest Patents
Antonio Maraver holds a patent for a combination treatment for cancer. This invention specifically addresses the treatment of lung cancer by analyzing the role of the Notch pathway in EGFR-driven lung adenocarcinoma. The findings indicate that combining EGFR tyrosine kinase inhibitors with Notch inhibition can re-sensitize lung adenocarcinoma cells to treatment. This innovative approach has the potential to improve outcomes for patients with specific mutations.
Career Highlights
Throughout his career, Antonio has worked with prestigious institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Montpellier. His research has focused on understanding the complexities of cancer biology and developing effective treatment strategies.
Collaborations
Antonio has collaborated with Emilie Bousquet, contributing to the advancement of cancer research and treatment methodologies.
Conclusion
Antonio Maraver's work in cancer treatment exemplifies the impact of innovative research on improving patient outcomes. His patented combination therapy represents a significant advancement in the fight against lung cancer.